Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
复制标题
DOI:
10.1016/j.bbalip.2013.09.009
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Anja Völzke;A. Koch;D. Meyer zu Heringdorf;A. Huwiler;J. Pfeilschifter
中科院分区:
文献类型:
--
作者:
Anja Völzke;A. Koch;D. Meyer zu Heringdorf;A. Huwiler;J. Pfeilschifter
Understanding the mechanisms of sphingosine 1-phosphate (S1P)-induced cyclooxygenase (COX)-2 expression and prostaglandin E2(PGE2) formation in renal mesangial cells may provide potential therapeutic targets to treat inflammatory glomerular diseases. Thus, we evaluated the S1P-dependent signaling mechanisms which are responsible for enhanced COX-2 expression and PGE2formation in rat mesangial cells under basal conditions. Furthermore, we investigated whether these mechanisms are operative in the presence of angiotensin II (Ang II) and of the pro-inflammatory cytokine interleukin-1β (IL-1β).Treatment of rat and human mesangial cells with S1P led to concentration-dependent enhanced expression of COX-2. Pharmacological and molecular biology approaches revealed that the S1P-dependent increase of COX-2 mRNA and protein expression was mediated via activation of S1P receptor 2 (S1P2). Further, inhibition of Giand p42/p44 MAPK signaling, both downstream of S1P2, abolished the S1P-induced COX-2 expression. In addition, S1P/S1P2-dependent upregulation of COX-2 led to significantly elevated PGE2levels, which were further potentiated in the presence of Ang II and IL-1β. A functional consequence downstream of S1P/S1P2signaling is mesangial cell migration that is stimulated by S1P. Interestingly, inhibition of COX-2 by celecoxib and SC-236 completely abolished the migratory response.Overall, our results demonstrate that extracellular S1P induces COX-2 expression via activation of S1P2and subsequent Giand p42/p44 MAPK-dependent signaling in renal mesangial cells leading to enhanced PGE2formation and cell migration that essentially requires COX-2. Thus, targeting S1P/S1P2signaling pathways might be a novel strategy to treat renal inflammatory diseases.